The news: WeightWatchers unveiled its new menopause treatment program, with Queen Latifah as its official spokeswoman.

• The program provides guidance from trained menopause clinicians and coaches. It also offers bundled weight loss services, including prescriptions for GLP-1s and hormone replacement therapy (HRT) via telehealth.
• WeightWatchers says that women gain around five to seven pounds during the menopause transition, on average.

Zooming out: WeightWatchers (a 62-year-old company) is changing its business model. It’s shifting from its traditional points-based nutrition programs and in-person meetings to offering prescription weight-loss drugs and marketing access to these treatments.

WeightWatchers joined the weight loss prescription drug market with the purchase of telehealth provider Sequence in May 2023. But the company filed for bankruptcy in May with $1.5 billion in debt. WeightWatchers struggled to determine how to provide traditional weight loss support to its existing customer base, as well as build a program around GLP-1 prescription access. Its subscriber base has dropped about 32% since 2020, per The Wall Street Journal.

The market opportunity: WeightWatchers is leaning into two growing categories of wellness treatments aimed at women—who account for over 90% of the company’s members.

• The highest rate of GLP-1 use is among women ages 50 to 64, per August 2025 RAND research.
• HRT has regained momentum as a solution for relieving common menopausal symptoms following a period of concern when it was believed that HRT put some women at greater risk for medical problems. But greater acceptance in recent years has driven a range of healthcare companies to offer HRT services.
• WeightWatchers cited Mayo Clinic research, which found that postmenopausal women receiving hormone therapy in combination with semaglutide achieved about 30% greater weight loss than those using the GLP-1 drug alone

Our take: WeightWatchers lost Oprah Winfrey as an ambassador last year, which hurt the company’s reputation. Adding Queen Latifah, who has already worked on obesity campaigns and spoken out about navigating menopause, signals that WeightWatchers is putting its full marketing power behind its new brand and commitment to core subscribers to compete increasingly crowded healthcare and prescription medication categories

To succeed against rivals like Hims & Hers and Noom, WeightWatchers needs to offer competitive pricing and secure more partnerships with major pharmaceutical companies to help raise awareness of its new focus in the growing wellness sector.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.